Authors
Latest:
Clinicians to Watch for Recalled Supplement That May Cause Solar PurpuraShanna Miranti, MPAS, PA-C, discusses the Umary hyaluronic acid tablets that were recalled in fall 2024.
Latest:
The Beauty-From-Within Market Continues to GrowThe dietary supplement industry seeks to help consumers age gracefully.
Latest:
Tolerability and Postcare Benefits of Laser Therapy for Patients With Pigmentary DisordersCorey Hartman, MD, FAAD, discusses how incorporating proper pre- and posttreatment protocols along with topical agents maximizes patient comfort and enhances treatment outcomes in laser therapy for pigmentary conditions.
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Latest:
Top Meeting Takeaways From the Fall Clinical ConferenceClinicians fresh from the Fall Clinical Dermatology Conference discuss their top meeting takeaways and share some recommendations.
Latest:
Psoriasis and Sunburn: New Study Highlights Increased Risk and Clinical ImplicationsSara Osborne, a fourth-year medical student and the lead author on the study, spoke with Dermatology Times on key findings and explain the need for further investigation.
Latest:
Treatment Switches and the Future of Hidradenitis Suppurativa ManagementPanelists discuss how identifying optimal timing for treatment switches and emerging therapeutic innovations are reshaping the management landscape for hidradenitis suppurativa, with the potential to improve long-term patient outcomes.
Latest:
Marcelo Bigal, MD, PhD: VENT-03's Modality Offers Hope for Targeted Therapy in Skin DisordersMarcelo Bigal, MD, PhD, discusses VENT-03's potential as a small molecule therapeutic in dermatology, among other fields.
Latest:
How to Effectively Partner with Patients to Optimize CareCombined, these efforts encourage active participation in the care process and drive sustained behavior change.
Latest:
AAD and VStrong Vitiligo Support Community Receive Inaugural Incyte Ingenuity Awards in VitiligoIncyte representative Todd Edwards discusses how the awards help address challenges faced by patients with vitiligo.
Latest:
Disseminated Erythema Migrans as a Result of Lyme DiseaseA 17-year-old male patient presents with multiple lesions developed on his trunk, face, and extremities that had previously been solitary, red expanding lesion on his right arm at the site of a tick bite that occurred during a hike.
Latest:
Talking to Patients About the Safety of JAK Inhibitors in Atopic DermatitisPanelists discuss how health care providers can effectively communicate the benefits and risks of JAK inhibitors to patients with atopic dermatitis while addressing safety concerns and establishing realistic treatment expectations.
Latest:
The Mainstream Patient: January 3, 2023This week's edition of the Mainstream Patient features stories about dry shampoos that don't contain benzene, the best ferulic acid serums, Hijabi hair care, and more.
Latest:
Customization Drives Pediatric Acne Treatment RegimensTreatment regimens for pediatric acne should consider skin type, ethnicity, disease severity and personal preferences, according to one expert.
Latest:
Addressing Causes of Female Hair Loss and Exploring Preventative MeasuresThis expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Latest:
Richard Gallo, MD, PhD: Updates on Understanding the Pathophysiology of AcneGallo presented pearls on the pathophysiology of acne and how newer studies have changed acne treatment methodologies at AAD 2024.
Latest:
Proper Coding Gets Practices What They Are OwedA physician’s goal is to care for patients, but a key part of being able to provide that care is the eternal quest for payment. One way to ensure that a practice maximizes its coding regimen is to make sure each session can be efficiently billed.
Latest:
Clinical Experience and Diagnosis of GPPPanelists discuss how clinical experience in diagnosing generalized pustular psoriasis (GPP) requires recognizing its hallmark features of widespread sterile pustules on inflamed skin, distinguishing it from other pustular conditions, and understanding the genetic mutations and triggers that can precipitate this rare but potentially life-threatening form of psoriasis.
Latest:
Tezepelumab Shows Sustained Post-Treatment Benefit in Chronic Spontaneous Urticaria Despite Missed Primary EndpointTezepelumab reduced CSU activity post-treatment through week 32, suggesting a delayed, sustained TSLP blockade effect.
Latest:
Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 TherapyChina’s NMPA has approved tunlametinib for the treatment of patients with NRAS-mutated advanced melanoma after prior anti–PD-1/PD-L1 therapy.
Latest:
Innovative Melanoma Treatment Among NCInnovation's $5.2 Million Research Funding RecipientsMichelle Bolas and Rukiyah T. Van Dross-Anderson, PhD, discuss the significance of NCInnovations’ funding and the clinical impact of Van Dross-Anderson's research in patients with advanced melanoma.
Latest:
Initiating and Navigating the Buy-and-Bill ProcessBiologic coordinators play a key role in managing insurance approvals and ensuring coverage details are confirmed quickly, often within 48 hours.
Latest:
Improving Representation of Skin of Color in DermatologyMiranda Uzoma Ewelukwa, MD, FAAD, reviews how skin of color representation has evolved in dermatology, however, more advocacy is still needed.
Latest:
The Adalimumab Biosimiliar Pipeline: What's AheadFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Latest:
How a digital front door can improve patients’ access to careOnline-first engagement ensures patients obtain the right care for their specific needs.
Latest:
Diagnosing Skin Conditions in Diverse Pediatric PatientsTraditional descriptions often cater to lighter skin, necessitating updates to better serve diverse populations.
Latest:
Post-Relapse Treatment of a 50-Year-Old Male Patient with VitiligoContinuing the discussion of a 50-year-old male patient with vitiligo, Anthony Nuara, MD, PhD, addresses the intricacies of treating patients who have relapsed or experienced a loss of efficacy following their initial treatment and highlights how to select 2nd line treatments with greater efficacy.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
